Pnd8 - Peginterferon Beta-1a Is Associated With Reduced Relapse Rates and Hospitalisations Due to Relapse Compared With Other First-Line Injectable Therapies for Multiple Sclerosis: Findings From a Real-World Cross-Sectional Study
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1975
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV